These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19155081)

  • 1. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis.
    Spahr L; Giostra E; Frossard JL; Bresson-Hadni S; Rubbia-Brandt L; Hadengue A
    J Hepatol; 2004 Aug; 41(2):229-34. PubMed ID: 15288471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
    Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
    Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
    Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
    Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
    Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
    Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis.
    Altamirano J; Fagundes C; Dominguez M; García E; Michelena J; Cárdenas A; Guevara M; Pereira G; Torres-Vigil K; Arroyo V; Caballería J; Ginès P; Bataller R
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):65-71.e3. PubMed ID: 21946124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
    Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
    Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.
    Naveau S; Chollet-Martin S; Dharancy S; Mathurin P; Jouet P; Piquet MA; Davion T; Oberti F; Broët P; Emilie D;
    Hepatology; 2004 May; 39(5):1390-7. PubMed ID: 15122768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.
    Spahr L; Rubbia-Brandt L; Frossard JL; Giostra E; Rougemont AL; Pugin J; Fischer M; Egger H; Hadengue A
    J Hepatol; 2002 Oct; 37(4):448-55. PubMed ID: 12217597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
    Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
    Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
    Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive aspergillosis in patients with severe alcoholic hepatitis.
    Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
    J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.
    Srikureja W; Kyulo NL; Runyon BA; Hu KQ
    J Hepatol; 2005 May; 42(5):700-6. PubMed ID: 15826720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
    Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
    J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD accurately predicts mortality in patients with alcoholic hepatitis.
    Dunn W; Jamil LH; Brown LS; Wiesner RH; Kim WR; Menon KV; Malinchoc M; Kamath PS; Shah V
    Hepatology; 2005 Feb; 41(2):353-8. PubMed ID: 15660383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.
    Singh V; Sharma AK; Narasimhan RL; Bhalla A; Sharma N; Sharma R
    Am J Gastroenterol; 2014 Sep; 109(9):1417-23. PubMed ID: 24935272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.